Amicus Therapeutics, Inc.' CEO John F. Crowley to Advocate for Rare and Orphan Disease Community in Washington, D.C. This Week
Published: Sep 11, 2013
CRANBURY, N.J., Sept. 11, 2013 (GLOBE NEWSWIRE) -- Amicus Therapeutics (Nasdaq:FOLD) today announced that John F. Crowley, Chairman and Chief Executive Officer, will advocate for the rare and orphan disease community at several upcoming events in Washington, D.C tomorrow on September 12, 2013:
Help employers find you! Check out all the jobs and post your resume.